Key Takeaways
- Record top line: Revenue climbed 48% YoY to $155.1M, a new quarterly high.
- Margin expansion: GAAP gross margin hit 37%, with non-GAAP gross margin in the mid-40s range.
- Loss narrows: GAAP net loss improved to $18.3M (-$0.03/sh).
- Cash strength: Cash & equivalents at ~$808M; management highlights >$1B total liquidity.
- Commercial momentum: 17 Electron launch contracts signed in the quarter; two HASTE missions executed for hypersonic testing.
- Defense push: GEOST acquisition closed (cash + equity, up to $325M), adding EO/IR payloads.
- Q4 2025 outlook: Revenue $170–180M; GAAP GM 37–39%; Adjusted EBITDA loss $23–29M.
- Neutron timeline: Vehicle arrives at LC-3 in Q1 2026; first launch to follow qualification.
Inside the Numbers: Q3 2025 Performance
Revenue & Mix
Rocket Lab delivered $155.1M in revenue for the quarter ended September 30, 2025, up 48% year over year. Growth remained balanced across Space Systems and Launch. Product revenue (spacecraft, subsystems, payloads) reached $104.0M, while service revenue (Electron/HASTE and related services) was $51.0M—nearly double vs. the prior year period.
Profitability
Gross profit rose to $57.3M, translating to 37% GAAP gross margin. Non-GAAP gross margin improved further (low-to-mid-40s), reflecting scale benefits and richer systems/payload mix. Operating loss widened sequentially on elevated R&D tied to Neutron and payload integration, but GAAP net loss tightened to $18.3M on favorable tax items and scale.
Liquidity & Balance Sheet
Rocket Lab ended Q3 with ~$808M in cash and cash equivalents and additional marketable securities that, together with ATM proceeds, underpin management’s >$1B liquidity claim—ample firepower to fund Neutron milestones and targeted M&A.
Related articles
Operational Highlights
- Launch cadence & backlog: The company signed 17 Electron launch contracts in Q3, an all-time quarterly record, and executed two HASTE missions for U.S. hypersonics—evidence of sticky demand for responsive lift and test services.
- National security expansion: Rocket Lab closed the GEOST acquisition (electro-optical/infrared payloads), rounding out its “end-to-end” stack—launch → spacecraft → payloads—and deepening exposure to programs like SDA and other defense architectures.
- Neutron milestones: Launch Complex-3 is open; Neutron is slated to arrive at LC-3 in Q1 2026, with first flight after qualification. The medium-lift vehicle remains the key unlock for larger constellation deployments and scale economics.
Guidance & What It Implies (Q4 2025)
- Revenue: $170–180M (healthy sequential growth).
- Margins: GAAP GM 37–39%; non-GAAP 43–45%—suggesting continued mix and scale benefits.
- Operating cadence: GAAP opex targeted in the $122–128M band (non-GAAP $107–113M).
- Profit trajectory: Adjusted EBITDA loss of $23–29M—another step toward breakeven as utilization and systems margins improve.
Investor read-through: The guide signals confidence in near-term demand across both segments despite elevated development spend. With liquidity >$1B and a record launch-contracting quarter, Rocket Lab is positioned to keep leaning into defense payloads while pushing Neutron toward its first flight.
The Strategic Picture: Three Things to Watch
- Margin durability as mix normalizes
Non-GAAP gross margins in the mid-40s hint at operating leverage from Space Systems and payload content. Watch component attach rates, spacecraft delivery schedules, and Electron pricing/mix to gauge sustainability. - Defense revenue conversion post-GEOST
Closing GEOST brings high-value EO/IR payload capability in-house. The slope of bookings—and conversion into deliveries—across U.S. national security programs will be a key KPI for 2026–2027. - Neutron execution risk vs. payoff
Neutron unlocks medium-lift TAM and larger constellation contracts, but timelines, capex discipline, and qualification milestones matter. Any slip affects the speed to EBITDA breakeven; any early wins could bend the curve positively.
Quick Stat Sheet (Q3 FY2025)
- Revenue: $155.1M (+48% YoY)
- GAAP Gross Margin: 37%
- GAAP EPS: -$0.03
- Adjusted EBITDA: negative (loss range detailed in guidance)
- Cash & equivalents: ~$807.9M; liquidity >$1B
- Contracts signed: 17 Electron launches; 2 HASTE missions executed
- Q4 revenue guide: $170–180M
- GEOST: acquisition closed (up to $325M)
- Neutron: LC-3 arrival Q1 2026; first launch post-qualification
Conclusion
Rocket Lab’s Q3 print checks the big boxes: record revenue, better margins, ample liquidity, and tangible defense expansion. The near-term story is still about executing a heavy launch/services manifest and scaling Space Systems, while the medium-term catalyst is Neutron. If margins hold and defense payloads scale, the path toward EBITDA improvement in 2026 looks increasingly achievable. Execution on Neutron—and the pace of defense contract conversions—will determine how quickly RKLB can translate growth into profitability.
FAQ
What is Rocket Lab’s ticker and exchange?
RKLB on the Nasdaq.
When were Q3 2025 results released?
November 10, 2025, covering the quarter ended September 30, 2025.
What drove the margin improvement?
Scale and mix within Space Systems and payload content, alongside improving manufacturing efficiency.
What’s new with Neutron?
Arrival at LC-3 in Q1 2026; inaugural mission to follow completion of qualification and acceptance testing.
How big is Rocket Lab’s liquidity?
Management indicates in excess of $1B (cash, securities, and recent ATM proceeds), supporting R&D and M&A.
Why is the GEOST deal important?
It adds EO/IR payloads—a high-value piece of the national security stack—making Rocket Lab a more complete prime for defense customers.
Disclaimer
This article is for informational and educational purposes only and does not constitute investment advice or a solicitation to buy or sell any security. Investing in equities—especially early-stage aerospace/defense—involves risk, including loss of principal. Do your own research and consider consulting a licensed financial professional before making investment decisions. Figures reflect company disclosures for Q3 FY2025 and may be updated in subsequent filings or presentations.
